NLRP3 and type 2 diabetes mellitus: MCC950 is a well-studied and specific NLRP3 inhibitor, which can alleviate the symptoms of mouse models of NLRP3-dependent disease, including NASH, type 2 diabetes, and Alzheimer’s disease [27].